Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/33329
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Launois, B. | - |
| dc.contributor.author | Maddern, G. | - |
| dc.date.issued | 2002 | - |
| dc.identifier.citation | British Journal of Surgery, 2002; 89(11):1345-1346 | - |
| dc.identifier.issn | 0007-1323 | - |
| dc.identifier.issn | 1365-2168 | - |
| dc.identifier.uri | http://hdl.handle.net/2440/33329 | - |
| dc.description | The definitive version is available at www.blackwell-synergy.com © John Wiley & Sons | - |
| dc.description.abstract | Reports that Hepatocellular carcinoma (HCC) is the most common cancer in men in Africa and Asia with 20-150 cases for every 150,000 inhabitants. Transplantation and surgical resection primary means of management; attempt to reduce postoperative tumor recurrence by use of Lipiodol before both transplantation and resection; Mechanism of action of Lipiodol. | - |
| dc.description.statementofresponsibility | B. Launois and G. Maddern | - |
| dc.language.iso | en | - |
| dc.publisher | John Wiley & Sons Ltd | - |
| dc.source.uri | http://dx.doi.org/10.1046/j.1365-2168.2002.02191.x | - |
| dc.subject | Liver -- Cancer | - |
| dc.subject | Excision (Surgery) | - |
| dc.title | Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol | - |
| dc.type | Journal article | - |
| dc.identifier.doi | 10.1046/j.1365-2168.2002.02191 | - |
| pubs.publication-status | Published | - |
| dc.identifier.orcid | Maddern, G. [0000-0003-2064-181X] | - |
| Appears in Collections: | Aurora harvest Surgery publications | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.